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Summary
Almost hundred years after the first demonstration of exact mass determination of 
chemical elements by J. J. Thomson’s in 1912, the method discovered by him – mass 
spectrometry – reached a high level of development in different fields of science and 
applications to life sciences, technology, medicine and public life. New aspects of ion-
ization of molecules from all aggregate states contributed largely to develop new ion 
sources for almost universal usage. By development of distinct ion optics the secondary 
ion beams can be manipulated in mass spectrometers, which may contain cells for ion 
concentration or fragmentation of entire ion clouds or their parts. Modern mass spec-
trometry is characterized by unique properties for research and analytics like specificity, 
sensitivity, speed, the possibility of automatization and of application of algorithms for 
interpretation of experimental data. These properties are already integrated in com-
mercial instruments and used for “omics”-type of projects, like genomics, proteomics, 
glycomics, lipidomics, and so on.
In this article, own investigations and method developments are presented, in which 
high resolution mass spectrometry, hyphenated techniques to MS and automated data 
interpretation are playing a crucial role. These technical solutions were applied to proj-
ects focussed to discovery of potential biomarker of human diseases. In the present vi-
sion of the future MS in medicine, MS imaging will play an important role. Using laser 
desorption for ionization, the images similar to those obtained by microscopy can be 
obtained, where they contain additionally also the information on the molecular struc-
ture as an extra value.
Keywords: Instrumentation for mass spectrometry, MALDI- and ESI-ionization, pro-
teomics, glycoproteomics, glycourinomics
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Abbreviations
EI  electron impact
ESI   electrospray ionization
MALDI   matrix-assisted laser desorption/ionization
FAB   fast atom bombardment
CID   collision induced dissociation
FD   field desorption
PD  plasma desorption
HPLC   high-performance liquid chromatography
Q-TOF   quadrupole/time-of-flight
TOF–TOF  time-of-flight/time-of-flight
m/z   mass-to-charge
MS   mass spectrometry
MS/MS   tandem mass spectrometry
IMS  ion mobility mass spectrometry
MSn   multiple stage mass spectrometry
PMF   peptide mass fingerprinting
ppm  parts per milion
PTM   post-translational modification
Mass spectrometry: historical remarks
The importance of mass spectrometry arose from its remarkable utility for 
studies of molecular structure and reaction mechanisms in a wide variety of 
contexts. In both its theoretical and experimental aspects, mass spectrometry 
does provide an integrative platform for discovery in numerous specialized 
areas of natural and life sciences. Thus, the significance of mass spectrometry 
to the research community encompasses presently wide area of physics, chem-
istry, biology, informatics and medicine, reflecting its unique interdisciplinary 
character. Since the discovery of separation of ions 
in the gas phase on the basis of mass to charge ratio 
in 1911 by Joseph John Thomson (1856-1940) as the 
“determination of atomic composition by mass” and 
followed by his student Francis William Aston (1877-
1945) mass spectrometry has developed into a gen-
eral field of great scope and power [1,2].
thomson and Aston determined the isotopic 
composition of the element neon in 1913 by „mass 
spectrograph“. Aston’s new mass spectrograph built 
in 1919 made use of a collimated beam deflected by 
Fig. 1. Joseph John Thomson (1856-1940)
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a parallel-plate electric field, passed through a slit, and deflected by a magnetic 
field to be recorded on a photographic plate. Masses were measured by inter-
polation between lines of known mass with an experimental error of 0.1%. By 
1921 Aston published his findings on the isotopic composition of several other 
elements, including Ar, Kr, Hg, and, of Cl. By 1925 the isotopic composition of 
over 50 elements had been determined, by 1933 the number had increased to 66, 
and by 1948 to 83 [3] However, development of laboratory instruments for mass 
spectrometry until mid-1940’s was still in infancy, where only four university 
laboratories in USA were doing mass spectrometric work, Minnesota, Princeton, 
Harvard, and Chicago.
Modern instrumentation for mass spectrometry
Electron-impact (EI) was a single established method for ionization for more 
than 30 years, where in a relatively harsh form of ionization process molecular 
ions as cation radicals m+. and their fragments were generated. Upon thermal va-
porization of the sample the vapor diffused into the electron beam and become 
ionized, depending on the electron energy which was controlled by the acceler-
ating potential on the ion trap electrode and accelerated to the analyser. Practical 
solutions to the quest for non-thermal evaporation of analytes from the solid or 
condensed phase to the gas phase appeared about 40 years ago, when the first 
cold ionization techniques, field desorption (FD) and plasma desorption (PD), 
followed by fast atom bombardment (FAB), were introduced. From this phase 
of development on, the ions were generated mostly in the external ion source 
and the refocused ion beam introduced to different types of mass analyzers. For 
FD ionization a high-potential electric field is applied to an carbon tip emitter, 
which was dipped to the solution of the analyte and briefly introduced into the 
ion source, producing molecular radical cations m+. or protonated molecular ion 
to be extracted into the mass analyzer [4]. In PD the 252Cf ion beam who hit the 
protein deposited on the polymer foil could be ionized and detected mostly as 
a singly charged species using the time-of-flight (TOF) detector [5].In FAB, the 
analyte in solution was deposited into a drop of a less-volatile liquid matrix and 
submitted to bombardment by a high energy beam of inert gas atoms Ar or Xe at 
4,000 to 10,000 eV [6]. The latter technique became largely popular, representing 
a relatively soft ionization technique and producing primarily intact cationized 
or anionized molecular ions, e.g. [M+H]+ and [M-H]–. The best resolution has 
been achieved at that time on sector instruments, consisting of magnetic and 
electrostatic analyzers in different geometries, and peptide and carbohydrates 
could be analyzed under such conditions [7,8]. Radical changes in the size of ion-
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ized molecular species came up with new techniques in the last century at the 
end of eighties, when laser desorption and electrospray ionization were present-
ed as revolutionary methods to ionize very large molecules softly as expressed 
by John Fenn under the motto “making elephants to fly” [9].
in the electrospray process of pro-
teins, first published 1989 by his group 
at the yale university, the ionization of 
intact macromolecules is taking place 
from solution in the electric field by 
formation of charged droplets on the 
capillary tip. These highly charged 
droplets shrink during the drying 
process and after entering the mass 
analyzer the distribution of their dif-
Fig. 2. John B. Fenn (*1917)
ferently charged states can be documented in mass spectra [10]. Less soft Des-
orption Ionisation/Laser Desorption Ionization (LDI) of intact proteins from the 
solid state was first presented in 1988 by the industrial research group led by 
Koichi Tanaka in Japan [11], an achievement which was also honoured by the 
Nobel prize committee in 2002 [12]. In the same year Matrix-Assisted Laser Des-
orption Ionization (MALDI) for ionization of intact macromolecules larger than 
100.000 Dalton was published by Franz Hillenkamp and Michael Karas from 
University of Münster in Germany, and became within short time a most popu-
lar method for protein and peptide analysis [13]. Using the Time-of-Flight (TOF) 
Analyzer, where the mass of the ionized species is measured by its time of flight, 
basically molecular species of any size could be detected, if well ionized. The 
present state-of-the-art in the size of molecules and assemblies was recorded to 
be 18 MDa virus protein coat, where the multiply charged molecular ions were 
detected by MALDI-TOF MS.
concerning mass analyzers, presently one of the most popular devices is the 
Paul’s ion trap. This radiofrequency quadrupole ion trap had its origins as far 
back as 1953, in the same patent as that in which Paul and Steinwedel at the Uni-
versity of Bonn first disclosed the operation of the quadrupole mass filter [14]. It 
has passed through several phases of development in which successive attempts 
have been made to exploit its potential for different analytical applications. At 
the same time there has been a distinct and parallel history of the evolution and 
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application of the trap in the field of atomic physics, culminating in being hon-
ored as one of the three co-recipients of the Nobel Prize for physics in 1989 [15].
Fourier Transform Ion Cyclotron Resonance (FTI-
CR) as the high-performance nondestructive image-
current detection device was introduced by Comisa-
row and Marshall in 1974 [16]. FTICR represents de 
facto a spectrometry as a tandem-in-time technique, 
meaning that all manipulations of the ions take place 
within the confines of a single space, but in tempo-
rally separate events. The ICR cell is located in the 
homogeneous region of a static magnetic field, where 
trapped ions undergo cyclotron motion in a plane 
perpendicular to the field at a frequency reflecting its 
Fig. 3. Wolfgang Paul (1913-1993)
mass-to-charge ratio. Confinement parallel to the magnetic-field lines is achieved 
by a static electric field generated by applying a small voltage onto two trapping 
plates that are oriented orthogonal to the magnetic field. The interactions of the 
ions with the magnetic and electric fields permit the ions to be trapped, ma-
nipulated, and ultimately detected. The frequencies of the image current can 
be measured to better than nine figures, corresponding to a mass measurement 
accuracy on the order of l part per billion (ppb), provided that a suitable mass 
calibration and multiple linear regression can be applied [17]. Gorshkov et al. 
determined by FTMS the mass of 20Ne to be 19.992440691(90)~with a precision 
that is a factor of 24 better than that in the 1983 Atomic Mass Evaluation; that 
latter measurement is based on nuclear reaction energy [18].
High mass resolution and the accurate determinations of ion mass and relative 
abundance are particularly important for the identification of the biological mol-
ecules, where the atomic composition information can be derived. For example, 
even with elemental composition restrictions that apply to a peptide containing 
some combination of the twenty common amino acids, 523 elemental composi-
tions are proposed within 25 ppm of the molecular mass accuracy of the relatively 
small peptide, substance P (MW= 1346.7121). An improvement in the accuracy of 
the mass measurement to 10 ppm causes the number to fall to just 13.
A novel hybrid instrument in which the linear trap quadrupole is linked to 
the orbitrap is a compact and less costly analyzer of high resolution and mass ac-
curacy developed by Alexander Makarov in 2000 [19] and shortly after brought 
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to the market. It is designed for protocols demanding for a short acquisition 
time and using a linear octopole collision cell, fragmentation analysis can be 
performed. Despite its relatively recent commercial introduction, the LTQ-Or-
bitrap has already proven to be a highly relevant analytical tool with a wide 
range of applications. Major applications are currently in proteomics, where its 
high resolving power (>150,000) and excellent mass accuracy of less than 1ppm 
under favourable conditions can contribute to significantly reduce false positive 
peptide identifications. A high number of publications appeared in this time 
window to report on identification of intact peptides and proteins of 3–150.000 
kDa, on drug and metabolite analysis, lipidomics and on molecular structure 
characterization using hydrogen/deuterium exchange measurements [20].
Proteomics: changing the paradigma
Proteomics evolved as a field in which the total protein expression profile 
studies of a particular cell, tissue, or organism, at a given time can be system-
atically and in parallel studied. Proteomics and other complementary analysis 
methods are essential components of the emerging ‘systems biology’ approach 
that seeks to comprehensively describe biological systems through integration 
of diverse types of data and, in the future, to ultimately allow computational 
simulations of complex biological systems [21].
The analytical techniques involve primarily a work-flow which include the 
two-dimensional gel electrophoresis separation, followed by a proteolytic diges-
tion of single spots, their extraction and peptide mass fingerprinting (PMF) by 
mass spectrometry, data analyses, and the use of databases [22]. In an alterna-
tive scenario, the total mixture is digested and submitted to the one- or two 
dimensional LC separation linked on-line to the mass spectrometer fitted with 
the ESI ion source or at-line to the analyzer fitted with a MALDI ion source. For 
the systematic study of the protein content under specific conditions, three main 
aspects must be efficiently solved by analytical methods: protein identification, 
characterization, and quantification. In clinical proteomics the study of disease-
related molecular changes is focussed toward the discovery of diagnostic mark-
ers and new therapeutic targets. Mapping molecular ions of peptides in prote-
olytic mixtures by PMF is not a sufficient requirement for identification, even at 
high resolution/high mass accuracy conditions. Fragmentation experiments by 
tandem MS protocols (MS/MS) add sequence information required for protein 
identification. Due to the complexity of the proteome numerous pitfalls faced by 
software, or from the MS/MS data are still possible [23].
35
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Recent efforts to integrate studies based on the targeted and the global ap-
proaches represent a promising strategy to be integrated to cell biology and bio-
medicine. Membrane proteomics is concerned with accurately and sensitively 
identifying molecules involved in cell compartmentalisation, including those 
controlling the interface between the cell and the outside world. Due to the high 
lipid content of the environment the protein material out of membranes must be 
isolated prior to HPLC-MS analysis. 
Monitoring of red blood cells (RBC) as the solely oxygen transporter in the 
organism of particular value for clinical proteomics was recently reviewed [24]. 
from experimentally obtained RBC proteomics data major understanding to-
ward interactions with plasma, endothelial cells, leukocytes, and platelets can 
be deduced, and matched to the deposits in open-access databases [25]. The con-
tribution of large-scale, high accuracy mass spectrometric equipment, like QTOF 
and FTICR-MS, in combination with selected biochemical procedures for sample 
preparation, will contribute largely to the increase of the protein identification 
score. In the case of RBC identified proteins can be categorized in terms of sub-
cellular localization, protein family, splice isoforms and functions. Encompass-
ing 600 membrane and soluble proteins identified in a single study, this data set 
provides interesting tool for further targeted explorations.
Glycoproteomics: revealing the most common proteome modification
According to intensive research over the last 50 years glycosylation appeared 
as one of the most common and diverse posttranslational modification (PTM) of 
eukaryotic proteins. Presumably more than 50% of all proteins are glycosylated 
[26], while their carbohydrate content varies from less than 1% to more than 90%, 
by weight. A variety of biological functions have been proposed for the carbohy-
drate part of glycoproteins: the blood group antigens are composed of oligosac-
charides bound to proteins or lipids, glycans are involved in the proper folding 
and the quality control of newly synthesized glycoproteins in the endoplasmic 
reticulum, and control the serum lifetime of glycoproteins, play a role in the 
polarized biosynthetic sorting of proteins, participate in the sperm-egg binding, 
just to mention a few. Glycosylation is a highly complex and dynamic process, 
which frequently results in the biosynthesis of multiple glycoforms of the same 
protein by either incomplete glycosylation or processing of the oligosaccarides.
There are two main types of protein glycosylation. For the N-glycosylation, the 
polypeptide sequence has to contain the consensus sequence asparagine-X-serine/threo-
nine (Asn-X-Ser/Thr, where X may be any amino acid except proline, Pro) in which the 
oligosaccharide is attached to the Asn residue via an N-glycosidic bond. O-glycosylation 
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occurs at Ser or Thr residues, but no general consensus sequence for O-glycosylation is 
known so far. Therefore the structural analysis of glycoproteins to reveal the glycosyla-
tion sites and the corresponding glycoforms is still a challenge.
glycan and peptide
structure
glycan and peptides 
structure
Fig. 4. Strategies for structure elucidation of N-glycosylated proteins [27].
Different strategies are in use for glycan mapping. N-linked oligosaccharide 
moieties are enzymatically released as glycosylamines from the polypeptide 
chain by peptide-N-glycosidase F (PNGase F) for mammalian glycoproteins or 
A (PNGase A) for plant glycoproteins (Fig. 4). The former site of N-glycosylation 
Asn residue is converted to aspartic acid (Asp) inducing a mass shift in the re-
maining peptide of roughly 1 Da. The characterization of the overall glycan ex-
pression pattern and the determination of the previously occupied glycosylation 
sites occurs in separate MS experiments using either glycan mapping by MALDI 
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demonstrated in the glycosylation pattern analysis of CDG patient plasma by in-
gel N-deglycosylation followed by MALDI TOF MS for rapid diagnosis [28]. Al-
ternatively, the proteolysis of the intact glycoproteins followed by identification 
using the on-line Hplc-ms and ms/ms should provide a direct information 
and overview of all glycan isoforms at the single site and encompass the glyco-
sylation status at all glycosylation sites. However, there are still major ongoing 
efforts to obtain a high coverage of all native glycopeptides present in proteolytic 
mixtures obtained from purified or mixted preparations of glycoproteins [29]. 
cell surface and extracellular proteins are o-glycosylated, where the most 
abundant type of O-glycosylation in proteins is the GalNAc attachment to serine 
(Ser) or threonine (Thr) in the protein chain by an ά-glycosidic linkage. Most 
eukaryotic nuclear and cytoplasmic proteins modified by ά-linked O-GlcNAc to 
Ser or Thr exhibit reciprocal O-GlcNAc glycosylation and phosphorylation dur-
ing the cell cycle, cell stimulation, and/or cell growth. Less investigated types 
of o-glycosylation are o-fucosylation, o-mannosylation, and o-glucosylation, 
but they are functionally of high relevance for early stages of development and 
for vital physiological functions of proteins. Glycosaminoglycans are ά-linked 
to proteoglycans via a xylose-containing tetrasaccharide, represented by linear 
chains of repetitive disaccharides modified by carboxylates and O- or/and N-
linked sulfates. Their functional role is described in crucial processes as coagu-
lation, wound healing, cell adhesion, inflammation and interaction with fibro-
blast growth factors, but their detailed molecular structure is in many cases still 
unknown [30].
Analysis of O-glycosylation by mass spectrometry (MS) is a complex task due 
to the high structural diversity of glycan and protein factors. The parameters in 
structural analysis of O-glycans include determination of (i) O-glycosylation at-
tachment sites in the protein sequence, (ii) the type of attached monosaccharide 
moiety, (iii) a core type in the case of GalNAc O-glycosylation, (iv) the type and 
size of the oligosaccharide portion, (v) carbohydrate branching patterns, (vi) the 
site of monosaccharide glycosidic linkages, (vii) the anomericity of glycosidic 
linkages, and (viii) covalent modifications of the sugar backbone chains by car-
bohydrate- and noncarbohydrate-type of substitutents [30].
Glycourinomics: a potential for biomarker discovery in human diseases
Enzymatic deficiencies of carbohydrate biosynthesis and metabolism are fre-
quently regarded as glycoproteinoses [31] giving rise to massive accumulation of 
glycopeptides excreted in urine. a-NAGA deficiency known also as Schindler’s 
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disease, is characterized by remarkable clinical heterogeneity, but patients with-
out overt clinical symptoms have been also reported. The polar mixtures of mid-
dle molecular weight between 500 and 5000 Daltons obtained by work-up proce-
dures of patients’ urine were proposed to contain possible biomarkers for early 
diagnostic evaluation and possible treatment. However, at the time of discovery 
there were no analytical methods capable to encompass the existing carbohy-
drate complexity and to contribute to identification of single excreted intact and 
truncated complex carbohydrates. According to the progress in development of 
instrumentation technical options for structure elucidation of metabolically ex-
creted glycans and glycopeptides by glycoscreening of complex mixtures by MS 
are becoming feasible [32]. 
The goal of metabolic screening is to identify all major and minor single 
components according to their m/z values as molecular ions in ms and to as-
sign them de-novo by an automatic algorithm. The importance of high-end in-
strumentation, in particular in high resolution/high accuracy has been under-
estimated in the past. We could show, that for de-novo automatic compositional 
assignment of intact molecular ions high mass accuracy is highly relevant, in 
Fig. 5. Identification of glycoconjugates from human urine by high accuracy FT-ICR mass spec-
trometry [33].
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which a number of previously unknown structures could be identified, which 
were overlapping in measurements on instruments with lower resolution.
Probing the analysis of urine samples by Fourier-transform ion cyclotron 
resonance mass spectrometry (FT ICR MS) under high resolving power and ac-
curacy in mass determination it was demonstrated that this approach could be 
particularly suited for complex carbohydrate profiling in native mixtures. Mul-
tiple stage fragmentation (MSn) on a FT ICR MS analyzer represents a particu-
lar advantage for structure determination of macromolecules, to provide high 
resolution and mass determination accuracy of the fragment ions at any stage of 
analysis. Particular attention has been consecrated to native sialylated glycans 
to prevent a possible loss of the NeuAc moiety due to the relative ease of its 
detachment by in-source fragmentation, requiring a careful optimization of the 
MS and tandem MS conditions. In experiments carried out by FT ICR SORI CID 
MS at 9.4 T glycoforms profile from urine of patients suffering from Schindler’s 
disease were obtained, and optimized MSn conditions provided a new option to 
analyze the degree of sialylation by the negative ion mode multistage analysis 
[32]. 
The FT ICR approach has been applied to screen urine of patients diagnosed 
with Congenital Disorders of Glycosylation (CDG) of unknown type. More than 
150 molecular species were detected in a single glycoconjugate fraction obtained 
from urine of a CDG patient by use of accurate mass determination under high 
resolution, in which overlapping nearly isobaric ionic species could be resolved 
and identified in a single MS stage by computer-assisted calculations. In combi-
nation with monosaccharide building block analysis, the considerations of non-
carbohydrate modifications, such as amino acids, phosphates and sulfates were 
taken into account. Taking advantage of this strategy the number of assigned 
peaks was significantly increased. Applying basic principles of N- and O-glycan 
assembling it was possible to indicate the type of the glycan involved accord-
ing to the ratio between numbers of hexoses and N-acetylhexosamines. The 
Hex3HexnAc2 unit can be associated with the pentasaccharide Man3glcnAc2 
as a common core for all types of N-glycans, while a ”high-mannose” type N-
glycan can be estimated according to the Hex/HexNAc ratio of 2:1 or higher. For 
the hybrid type N-glycan this ratio decreases, whereas the complex type is char-
acterized by the lowest ratio. In O-glycans the ratio is 1:1 or lower [33].
for de-novo sequence assignment of single components from fragmentation 
analysis by MS/MS the overlapping is a problem as well, which was investi-
gated using the separation in the gas phase by ion mobility mass spectrometry 
[34]. Probing the IMS approach together with de-novo automatic assignment ac-
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cording to fragmentation patterns high-efficiency procedure for glycourinomics 
could be designed [35,36]. 
Conclusions
A major change in paradigma took place within the last two decades turn-
ing our way of designing and performing experiments in life sciences, beyond 
reductionism approach to the systems biology. Development of analytical tools 
and instruments reached a mature stage for high accuracy/high speed data ac-
quisition. Recent efforts to integrate studies based on the targeted and the global 
“omics” approaches represent a promising strategy to be integrated to cell biol-
ogy and biomedicine. Mass spectrometry appears presently as a global analyti-
cal method, which is aimed to be integrated in different type of strategies for 
biomedical projects to increase the efficiency of identification and speed of data 
acquisition. High perspectives can be forecasted for use of mass spectrometry in 
diagnostics of human diseases and for new concepts in studies toward discovery 
and validation of biomarker molecules and their profiles. Identification, valida-
tion and quantification are strictly required to increase the output of proteomics 
in systems biomedicine. The targeted proteomics can contribute more validated 
evidence then in the data-driven experiments [37]. Glycomics, still underdevel-
oped in comparison to proteomics, will be in focus for the next decade, in which 
robust integrated platforms will be necessary to validate high-throughput pro-
cedures. Novel MS systems for tissue microscopy and for the surface ablation 
will probably play an interesting integrative role for interdisciplinary projects 
between medical practitioners and basic scientists. such molecular imaging of 
proteins in rat brain tissues by mass spectrometry were already shown, where 
the images are constructed at spatial localization with a lateral resolution of 
10–100 μm [38].
on the other side the technical progress into miniaturization, automatiza-
tion and nanodevices for sample delivery [39] will largely contribute to in-depth 
investigations, concerning in particular the identification of components barely 
visible in the mixtures of high dynamic range and open new horizons for de-
velopment of in-care devices. Construction and curation of general extended 
data bases as well as those focussed for distinct applications will enable a rapid 
access to the accumulated knowledge for comparison and data mining. A con-
cept of tight collaboration between biochemists and bioinformaticians on one 
side could give rise to higher efforts to establish robust software for automatic 
assignment of acquired MS data and their automatic deposition in data bases. 
On the other side a tight collaboration between medical practitioners and ba-
41
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sic scientists will be necessary for new protocols for standardization of clinical 
samples’ preparation and storage. 
The platforms based on integration of the aspects described above will rep-
resent a beginning of more efficient, more rapid and less costly health care, based 
on systems biology, in which a close placement of MS to the patients’ bedside 
may become possible. Many challenges are still to be overcome.
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Sažetak
O spektrometriji masa u molekularnoj medicini: od elementarne analize
do dijagnostičkog slikanja
Gotovo sto godina nakon što je J. J. Thomson’s 1912. prvi put pokazao da se masa kemijskih 
elemenata može eksperimentalno točno odrediti metoda koju je on otkrio – spektrometrija masa 
– dosegla je visok stupanj razvitka i raznolikosti na raznim poljima znanosti i svoje primjene u 
tehnologiji, medicini i javnom životu. Nove spoznaje o ioniziranju molekula iz svih agregatnih 
stanja omogućile su razvoj novih ionskih izvora za gotovo univerzalne primjene. Razvojem in-
strumentalne ionske optike omogućeno je manipuliranje ionskih zraka u spektrometrima masa, 
koji sadrže ćelije za ili sakupljanje ili fragmentiranje čitavih ionskih oblaka ili njihovih dijelova. 
Moderna spektrometrija masa raspolaže jedinstvenim svojstvima za istraživanje i analitiku kao 
što su specifičnost, osjetljivost, brzina, mogućnost automatizacije i primjene algoritama za in-
terpretaciju eksperimentalnih podataka. Sve te instrumentalne metode danas su već u cijelosti 
integrirane u „omics“ poljima istraživanja kao što su genomics, proteomics, glycomics, lipidomics 
itd.
Ovdje su prikazana pojedina autoričina istraživanja razvitka metoda za visokorazlučenu 
spektrometriju masa i za njezino direktno priključivanje na instrument za razdjeljivanje te razvit-
ka algoritama za interpretaciju eksperimentalnih podataka. Ta tehnička rješenja bila su primije-
njena na projekte usredočene na otkrivanje potencijalnih biomarkera u ljudskim bolestima. U 
momentalnoj viziji primjene spektrometrije masa u medicini se već ocrtava dijagnostičko slika-
nje, pri čemu se laserskom desorpcijom dobivaju slike slične onima dobivenima mikroskopijom, 
ali koje sadrže i dodatnu informaciju o molekularnim strukturama.
Ključne riječi: Instrumentarij za spektrometriju masa; MALDI- i ESI-ionizacija; proteomika; 
glikoproteomika; glikourinomika
